Last year, the FDA came down hard on a Sanofi Pasteur plant in Toronto. The ensuing trouble triggered serious supply problems--and, in turn, a shortage of childhood vaccines in the U.S.
Craig Venter has revealed more details of his plans for printable vaccines and antibiotics in an interview with The Guardian.
Getting vaccines to stay in mucosal membranes long enough to trigger an immune response can be tricky. Engineers have now developed nanoparticles to carry vaccines to the mucosal surface in the lungs, protecting them long enough to provoke an immune response.
Analysts predicted Merck shingles vaccine Zostavax would be a blockbuster when it was first released in 2006. But Merck quickly ran into manufacturing and supply issues, putting a damper on sales and expectations. A $1 billion upgrade has put its production problems behind it and posed Merck for expansion even as demand for Zostavax has jumped.
Novartis' Bexsero may be the only vaccine approved for life-threatening meningitis B, but that wasn't enough to convince the U.K.'s Joint Committee on Vaccination and Immunisation to add it to Britain's routine vaccination schedule.
One reason Pfizer snapped up Wyeth in 2009: Its Prevnar/Prevenar vaccine franchise. Now, the latest version of the pneumococcal shot is Pfizer's fourth-biggest seller, with $3.72 billion in 2012 revenues. But Pfizer wants even more.
As the H7N9 avian influenza outbreak in China grows, global leaders are becoming increasing concerned that the deadly flu virus could mutate into a pandemic.
GlaxoSmithKline has been listening to parents' concerns about childhood vaccinations. Really listening. In fact, it has used big data analytics to sift through thousands of comments from Internet chat forums to try to get a better grasp of exactly what objections there are and how to best face them.
The rise of the Internet--and social networks in particular--has provided a way of tracking the spread of ideas, the way an epidemiologist follows a virus. Now researchers have used this analytical approach to track the viral spread of opinions about vaccines.
Public health experts are worried about the latest numbers on HPV vaccine uptake. After all, the shots can prevent cervical cancer, and that's no small thing. so, with a majority of girls eschewing the shots, government officials and others are trying to figure out how to turn the tide.